Risk assessment for vitamin D

American Journal of Clinical Nutrition

Volumn 85, Issue 1, 2007, Pages 6-18

  Hathcock, John N ^a   Shao, Andrew ^a   Vieth, Reinhold ^b   Heaney, Robert ^c  

^a International and Scientific Affairs   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

^c CREIGHTON UNIVERSITY   (United States)

Author keywords

Risk assessment; Tolerable upper intake level; UL; Vitamin D

Indexed keywords

CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; FLUORIDE SODIUM; HYDROCHLOROTHIAZIDE; PREDNISONE;

CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HYPERCALCEMIA; LOW DRUG DOSE; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SUN EXPOSURE; VITAMIN INTAKE;

EID: 33846047531     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/85.1.6     Document Type: Review

References (99)

1. Giovannucci E. The epidemiology of vitamin D and colorectal cancer: recent findings. Curr Opin Gastroenterol 2006;22:24-9.
2. Giovannucci E, Liu Y, Rimm EB, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006;98:451-9.
3. Grau MV, Baron JA, Sandler RS, et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 2003;95:1765-71.
4. Holt PR, Bresalier RS, Ma CK, et al. Calcium plus vitamin D alters preneoplastic features of colorectal adenomas and rectal mucosa. Cancer 2006;106:287-96.
5. Kenny AM, Biskup B, Robbins B, Marcella G, Burleson JA. Effects of vitamin D supplementation on strength, physical function, and health perception in older, community-dwelling men. J Am Geriatr Soc 2003;51:1762-7.
6. Bischoff HA, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003;18:343-51.
7. Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 2005;28:2926-32.
8. Haworth CS, Jones AM, Adams JE, Selby PL, Webb AK. Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis. J Cyst Fibros 2004;3:233-6.
9. Holick MF. Vitamin D. Its role in cancer prevention and treatment. Prog Biophys Mol Biol 2006;92:49-59.
10. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81:353-73.
11. Food and Nutrition Board. Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academy Press, 1997.
12. Scientific Committee on Food. Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of vitamin D. Brussels, Belgium:European Commission, 2002.
13. Expert Group on Vitamins and Minerals. Safe Upper Levels for vitamins and minerals. London, United Kingdom: Food Standards Agency, 2003.
14. Narang NK, Gupta RC, Jain MK. Role of vitamin D in pulmonary tuberculosis. J Assoc Physicians India 1984;32:185-8.
15. Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001;73:288-94.
16. International standard for vitamin D. WHO Technical Report Series. Geneva, Switzerland: World Health Organization, 1950.
17. 2. Am J Clin Nutr 1998;68:854-8.
18. Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004;89:5387-91.
19. Food and Nutrition Board, Institute of Medicine. A risk assessment model for establishing upper intake levels for nutrients. Washington, DC: National Academy Press, 1998.
20. Stern PH, Taylor AB, Bell NH, Epstein S. Demonstration that circulating 1 alpha, 25-dihydroxyvitamin D is loosely regulated in normal children. J Clin Invest 1981;68:1374-7.
21. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469-75.
22. Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int 1998;8:222-30.
23. th Vitamin D Workshop: Victoria, Canada 2006 (abstr).
24. Hasling C, Nielsen HE, Melsen F, Mosekilde L. Safety of osteoporosis treatment with sodium fluoride, calcium phosphate and vitamin D. Miner Electrolyte Metab 1987;13:96-103.
25. Rickers H, Deding A, Christiansen C, Rodbro P, Naestoft J. Corticosteroid-induced osteopenia and vitamin D metabolism. Effect of vitamin D2, calcium phosphate and sodium fluoride administration. Clin Endocrinol (Oxf) 1982;16:409-15.
26. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003;77:204-10.
27. Berlin T, Emtestam L, Bjorkhem I. Studies on the relationship between vitamin D3 status and urinary excretion of calcium in healthy subjects: effects of increased levels of 25-hydroxyvitamin D3. Scand J Clin Lab Invest 1986;46:723-9.
28. Berlin T, Bjorkhem I. Lack of effects of an increased pool of 25-hydroxyvitamin D3 on urinary excretion of calcium in healthy subjects. Contrib Nephrol 1987;58:143-7.
29. Vieth R, Kimball S, Hu A, Walfish PG. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J 2004;3:8-18.
30. Hollis BW, Wagner CL. Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant. Am J Clin Nutr 2004;80(suppl):1752S-8S.
31. Tjellesen L, Hummer L, Christiansen C, Rodbro P. Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women. Bone Miner 1986;1:407-13.
32. Nordin BE, Baker MR, Horsman A, Peacock M. A prospective trial of the effect of vitamin D supplementation on metacarpal bone loss in elderly women. Am J Clin Nutr 1985;42:470-4.
33. Stefikova K, Chylova K, Krivosikova Z, Spustova V, Dzurik R. [Intensive vitamin D supplementation in the treatment of osteoporosis]. Vnitr Lek 2004;50:286-90 (in Slovak).
34. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006;83:754-9.
35. Aloia JF, Talwar SA, Pollack S, Yeh J. A randomized controlled trial of vitamin D3 supplementation in African American women. Arch Intern Med 2005;165:1618-23.
36. 2D. Am J Clin Nutr 1990;52:701-6.
37. Johnson KR, Jobber J, Stonawski BJ. Prophylactic vitamin D in the elderly. Age Aging 1980;9:121-7.
38. Honkanen R, Alhava E, Parviainen M, Talasniemi S, Monkkonen R. The necessity and safety of calcium and vitamin D in the elderly. J Am Geriatr Soc 1990;38:862-6.
39. Stamp TC, Haddad JG, Twigg CA. Comparison of oral 25- hydroxycholecalciferol, vitamin D, and ultraviolet light as determinants of circulating 25-hydroxyvitamin D. Lancet 1977;1:1341-3.
40. Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 1995;61(suupl):638S-45S.
41. Haddad JG, Chyu KJ. Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab 1971;33:992-5.
42. Haddock L, Corcino J, Vasquez MD. 25(OH)D serum levels in the normal Peurto Rican population and in subjects with tropical sprue and parathyroid disease. Peurto Rico Health Sci J 1982;1:85-91.
43. Barger-Lux MJ, Heaney RP. Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab 2002;87:4952-6.
44. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69:842-56.
45. Mason RS, Posen S. The relevance of 25-hydroxycalciferol measurements in the treatment of hypoparathyroidism. Clin Endocrinol (Oxf) 1979;10:265-9.
46. Morris HA. Vitamin D. A hormone for all seasons - how much is enough? Understanding the new pressures. Clin Biochem Rev 2005;26:21-32.
47. Rizzoli R, Stoermann C, Ammann P, Bonjour JP. Hypercalcemia and hyperosteolysis in vitamin D intoxication: effects of clodronate therapy. Bone 1994;15:193-8.
48. Todd MA, Bailey RR, Espiner EA, Lynn KL. Vitamin D2 for the treatment of chilblains - a cautionary tale. N Z Med J 1987;100:465.
49. Barrueto F Jr, Wang-Flores HH, Howland MA, Hoffman RS, Nelson LS. Acute vitamin D intoxication in a child. Pediatrics 2005;116:E453-6.
50. Vieth R, Pinto TR, Reen BS, Wong MM. Vitamin D poisoning by table sugar. Lancet 2002;359:672.
51. Koutkia P, Chen TC, Holick MF. Vitamin D intoxication associated with an over-the-counter supplement. N Engl J Med 2001;345:66-7.
52. Selby PL, Davies M, Marks JS, Mawer EB. Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate. Clin Endocrinol (Oxf) 1995;43:531-6.
53. Pettifor JM, Bikle DD, Cavaleros M, Zachen D, Kamdar MC, Ross FP. Serum levels of free 1,25-dihydroxyvitamin D in vitamin D toxicity. Ann Intern Med 1995;122:511-3.
54. Blank S, Scanlon KS, Sinks TH, Lett S, Falk H. An outbreak of hypervitaminosis D associated with the overfortification of milk from a home-delivery dairy. Am J Public Health 1995;85:656-9.
55. Jacobus CH, Holick MF, Shao Q, et al. Hypervitaminosis D associated with drinking milk. N Engl J Med 1992;326:1173-7.
56. Jansen TL, Janssen M, de Jong AJ. Severe hypercalcaemia syndrome with daily low-dose vitamin D supplementation. Br J Rheumatol 1997;36:712-3.
57. Mawer EB, Hann JT, Berry JL, Davies M. Vitamin D metabolism in patients intoxicated with ergocalciferol. Clin Sci (Lond) 1985;68:135-41.
58. Schwartzman MS, Franck WA. Vitamin D toxicity complicating the treatment of senile, postmenopausal, and glucocorticoid-induced osteoporosis. Four case reports and a critical commentary on the use of vitamin D in these disorders. Am J Med 1987;82:224-30.
59. Vieth R. The mechanisms of vitamin D toxicity. Bone Miner 1990;11:267-72.
60. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669-83.
61. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 1997;126:497-504.
62. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol 2004;15:3225-32.
63. Curhan GC, Willett WC, Knight EL, Stampfer MJ. Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch Intern Med 2004;164:885-91.
64. Williams CP, Child DF, Hudson PR, et al. Why oral calcium supplements may reduce renal stone disease: report of a clinical pilot study. J Clin Pathol 2001;54:54-62.
65. Trinchieri A, Nespoli R, Ostini F, Rovera F, Zanetti G, Pisani E. A study of dietary calcium and other nutrients in idiopathic renal calcium stone formers with low bone mineral content. J Urol 1998;159:654-7.
66. Messa P, Marangella M, Paganin L, et al. Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones. Clin Sci (Lond) 1997;93:257-63.
67. Block G, Port FK. Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease. Semin Dial 2003;16:140-7.
68. McCullough PA, Sandberg KR, Dumler F, Yanez JE. Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review. J Nephrol 2004;17:205-15.
69. Locatelli F, Cannata-Andia JB, Drueke TB, et al. Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Nephrol Dial Transplant 2002;17:723-31.
70. Norman PE, Powell JT. Vitamin D, shedding light on the development of disease in peripheral arteries. Arterioscler Thromb Vasc Biol 2005;25:39-46.
71. Haffner D, Hocher B, Muller D, et al. Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3. J Hypertens 2005;23:1067-75.
72. Lamawansa MD, Wysocki SJ, House AK, Norman PE. Vitamin D3 exacerbates intimal hyperplasia in balloon-injured arteries. Br J Surg 1996;83:1101-3.
73. Wolisi GO, Moe SM. The role of vitamin D in vascular calcification in chronic kidney disease. Semin Dial 2005;18:307-14.
74. Vieth R, Scragg R. Vitamin D nutrition does not cause peripheral artery disease. Arterioscler Thromb Vasc Biol 2005;25:e41 (letter); author reply e41-2.
75. Toda T, Ito M, Toda Y, Smith T, Kummerow F. Angiotoxicity in swine of a moderate excess of dietary vitamin D3. Food Chem Toxicol 1985;23:585-92.
76. Toda T, Toda Y, Kummerow FA. Coronary arterial lesions in piglets from sows fed moderate excesses of vitamin D. Tohoku J Exp Med 1985;145:303-10.
77. Montgomery JL, Parrish FC Jr, Beitz DC, Horst RL, Huff-Lonergan EJ, Trenkle AH. The use of vitamin D3 to improve beef tenderness. J Anim Sci 2000;78:2615-21.
78. Wilborn BS, Kerth CR, Owsley WF, Jones WR, Frobish LT. Improving pork quality by feeding supranutritional concentrations of vitamin D3. J Anim Sci 2004;82:218-24.
79. Montgomery JL, Carr MA, Kerth CR, et al. Effect of vitamin D3 supplementation level on the postmortem tenderization of beef from steers. J Anim Sci 2002;80:971-81.
80. Anning ST, Dawson J, Dolby DE, Ingram JT. The toxic effects of calciferol. Quart J Med 1948;67:203-28.
81. Sharma OP. Vitamin D, calcium, and sarcoidosis. Chest 1996;109:535-9.
82. Dai G, Phalen S, McMurray DN. Nutritional modulation of host responses to mycobacteria. Front Biosci 1998;3:e110-22.
83. Zawada ET Jr, Lee DB, Kleeman CR. Causes of hypercalcemia. Postgrad Med 1979;66:91-7, 99-100.
84. Crowe M, Wollner L, Griffiths RA. Hypercalcaemia following vitamin D and thiazide therapy in the elderly. Practitioner 1984;228:312-3.
85. Seikaly MG, Baum M. Thiazide diuretics arrest the progression of nephrocalcinosis in children with X-linked hypophosphatemia. Pediatrics 2001;108:E6.
86. Parfitt AM. The interactions of thiazide diuretics with parathyroid hormone and vitamin D. Studies in patients with hypoparathyroidism. J Clin Invest 1972;51:1879-88.
87. Food and Nutrition Board. Institute of Medicine. Dietary Reference Intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium and zinc. Washington, DC: National Academy Press, 2001.
88. Booth SL, Tucker KL, McKeown NM, Davidson KW, Dallal GE, Sadowski JA. Relationships between dietary intakes and fasting plasma concentrations of fat-soluble vitamins in humans. J Nutr 1997;127:587-92.
89. Weaver CM, Fleet JC. Vitamin D requirements: current and future. Am J Clin Nutr 2004;80(suppl):1735S-9S.
90. Calvo MS, Whiting SJ, Barton CN. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr 2004;80(suppl):1710S-6S.
91. Parikh SJ, Edelman M, Uwaifo GI, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 2004;89:1196-9.
92. Snijder MB, van Dam RM, Visser M, et al. Adiposity in relation to vitamin Dstatus and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 2005;90:4119-23.
93. Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 2003;88:157-61.
94. Alvarez-Leite JI. Nutrient deficiencies secondary to bariatric surgery. Curr Opin Clin Nutr Metab Care 2004;7:569-75.
95. Holick MF. Vitamin D. The underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Op Endocrinol Diabetes 2002;9:87-98.
96. Webb AR, DeCosta BR, Holick MF. Sunlight regulates the cutaneous production of vitamin D3 by causing its photodegradation. J Clin Endocrinol Metab 1989;68:882-7.
97. Heaney RP. The Vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005;97:13-9.
98. Vieth R, Carter G. Difficulties with vitamin D nutrition research: objective targets of adequacy, and assays for 25-hydroxyvitamin D. Eur J Clin Nutr 2001;55:221-2;discussion:306-7.
99. Vieth R. Critique of the considerations for establishing tolerable upper intake levels for vitamin D: critical need for revision upwards. J Nutr 2006;136:1117-22.